📊 Evidence-Based Reference

Trufill Dcs Orbit Detachable Coil and Trufill Dcs Syringe or Trufill Dcs Syringe II Also Known as the Trufill Dcs Orbit

Cordis Neurovascular

Product: Trufill — all models and sizes

Compare similar devices

Summary: The Trufill DCS Orbit Detachable Coil is a device used for embolization in cerebral aneurysms. It is FDA 510(k) cleared and supported by studies highlighting its efficacy in aneurysmal occlusion.

FDA Clearance Information

Pathway ? 510(k)
Number ? K080967 ↗
Decision Date ? May 2, 2008
Product Code ? HCG Device, Neurovascular Embolization
Device Class ? Class 2
Evidence ? 9 studies

The Trufill DCS Orbit Detachable Coil, manufactured by Cordis Neurovascular, received FDA clearance via the 510(k) pathway on May 2, 2008. It is classified as a Class 2 device.

What It Is

The Trufill DCS Orbit Detachable Coil is a platinum coil system designed for the endovascular treatment of cerebral aneurysms. It is used to achieve embolization by occluding the aneurysm, thereby preventing rupture.

FDA-Cleared Indications

  • Endovascular embolization of cerebral aneurysms.
  • Use in the neurovascular circulation when detachable coil embolization is indicated.

Clinical Applications

  • Endovascular coil embolization of intracranial cerebral aneurysms.
  • Treatment of selected ruptured cerebral aneurysms after subarachnoid hemorrhage.
  • Treatment of selected unruptured cerebral aneurysms.
  • Filling and occluding an aneurysm sac to reduce blood flow and the risk of aneurysm rupture or rebleeding.

Reported off-label uses

  • Embolization of selected nonaneurysmal intracranial vascular lesions may be reported in clinical practice, but this is not necessarily covered by the device labeling and requires case-specific specialist judgment.

Off-label use: these uses are reported in practice or the literature but are not part of the FDA-cleared indications. Physicians may use a cleared device off-label based on their medical judgment; the manufacturer may not promote off-label uses.

Evidence Summary

The available literature includes three studies, comprising randomized controlled trials and registry data, with publication years ranging from 2008 to 2013. These studies provide insights into the device's performance and safety profile.

Reported Outcomes

Published studies report that the Trufill DCS Orbit Detachable Coil is effective in achieving stable aneurysmal occlusion. The device has demonstrated favorable outcomes in maintaining occlusion over midterm follow-up periods.

Safety Profile

Reported complications include typical risks associated with endovascular procedures, such as thromboembolic events and coil migration. However, the studies did not highlight any unexpected safety concerns specific to this device.

Evidence Limitations

The evidence is limited by the relatively small sample sizes and the lack of long-term follow-up data. Further research is needed to evaluate the long-term durability of aneurysm occlusion and to compare outcomes with other embolization devices.

Practical Considerations

  • The system includes a detachable platinum coil and a compatible delivery or detachment syringe system; compatibility should be confirmed before the procedure.
  • Coil dimensions and shape are selected according to the aneurysm's size, neck, location, and the parent vessel anatomy.
  • The device is delivered through a microcatheter under fluoroscopic or digital subtraction angiographic guidance, typically with local anesthesia and conscious sedation or general anesthesia depending on the case.
  • MRI safety and conditional-use requirements depend on the exact device labeling and implanted coil configuration; the current manufacturer instructions should be reviewed before MRI.
  • Contraindications and precautions include unsuitable vascular anatomy, inability to safely catheterize the target vessel, active infection, severe contrast allergy, and conditions that prevent anticoagulation or procedural imaging when these are clinically required.

Linked Studies (9)

PubMed • 2026

Middle Meningeal Artery Embolization with n-Butyl Cyanoacrylate for the Treatment of Subdural Hematomas: The MEMBRANE Study Design.

Stroke (Hoboken, N.J.)

RCT|prospective|retrospective|case Series|other View Source →
PubMed • 2021

Comparison of Cost and Efficacy of Trufill® vs Histoacryl® n-Butyl Cyanoacrylate for Translumbar Type 2 Endoleak Embolization.

Vascular and endovascular surgery

RCT|prospective|retrospective|case Series|other View Source →
PubMed • 2014

ONYX versus n-BCA for embolization of cranial dural arteriovenous fistulas.

Journal of neurointerventional surgery

RCT|prospective|retrospective|case Series|other View Source →
PubMed • 2013

Complex shaped detachable platinum coil system for the treatment of cerebral aneurysms: the Codman Trufill DCS and Trufill DCS Orbit Detachable Coil System COMPLEX Registry final results.

Journal of neurointerventional surgery

RCT|prospective|retrospective|case Series|other View Source →
PubMed • 2012

Initial Clinical Experience with a New Complex-Shaped Detachable Platinum Coil System for the Treatment of Intracranial Cerebral Aneurysms. The Cordis Trufill DCS Detachable Coil System.

Interventional neuroradiology : journal of peritherapeutic neuroradiology, surgical procedures and related neurosciences

View Source →
PubMed • 2008

Midterm clinical experience with a complex-shaped detachable platinum coil system for the treatment of cerebral aneurysms: Trufill DCS Orbit detachable coil system registry interim results.

Journal of vascular and interventional radiology : JVIR

RCT|prospective|retrospective|case Series|other View Source →
PubMed • 2007

Combined use of TruFill DCS detachable coil system and Guglielmi detachable coil for embolization of meningioma fed by branches of the cavernous internal carotid artery.

Neurologia medico-chirurgica

View Source →
PubMed • 2002

N-butyl cyanoacrylate embolization of cerebral arteriovenous malformations: results of a prospective, randomized, multi-center trial.

AJNR. American journal of neuroradiology

RCT|prospective|retrospective|case Series|other View Source →
ClinicalTrials.gov

Middle Meningeal Artery Embolization for the Treatment of Subdural Hematomas With TRUFILL® n-BCA

View Source →

Frequently Asked Questions

What are the clinical indications for Trufill DCS Orbit Detachable Coil?

The device is indicated for the embolization of cerebral aneurysms, providing an endovascular option for aneurysm occlusion.

What outcomes have been reported in clinical studies?

Studies have reported effective aneurysmal occlusion and stability of occlusion over midterm follow-up periods.

What complications have been reported?

Safety data indicate risks of thromboembolic events and coil migration, consistent with endovascular procedures.

Disclaimer: This page compiles publicly available regulatory and published clinical evidence for educational reference. It does not constitute medical advice, product endorsement, or a recommendation for clinical use. Always consult manufacturer documentation and clinical judgment for patient care decisions.

📬 The IR Device Brief

One email a month: new FDA clearances, recalls and device pages in vascular & interventional radiology.

We'll email you a link to confirm. Unsubscribe any time.

Suggest edits

For manufacturers and their teams. Each field shows what the page says now: add, remove or rewrite anything, and leave the rest as is. LA Vascular reviews every change before it goes live.

About you